Defining the endpoints: how to measure the efficacy of drugs that are active against central nervous system metastases

by Fabi, Alessandra, Vidiri, Antonello
Published in Transl Lung Cancer Res (2016)

First-line therapy in HER2 positive metastatic breast cancer: is the mosaic fully completed or are we missing additional pieces?

by Fabi, Alessandra, Malaguti, Paola, Vari, Sabrina, Cognetti, Francesco
Published in J Exp Clin Cancer Res (2016)

Activity of Eribulin Mesylate in Brain Metastasis from Breast Cancer: A Stone in a Pond?

by Catania, Giovanna, Malaguti, Paola, Gasparro, Simona, Cognetti, Francesco, Vidiri, Antonello, Fabi, Alessandra
Published in Oncology (2018)

RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives

by Infante, Marco, Fabi, Alessandra, Cognetti, Francesco, Gorini, Stefania, Caprio, Massimiliano, Fabbri, Andrea
Published in J Exp Clin Cancer Res (2019)

CMET-31. THE ROLE OF SURGERY IN THE COMBINED TREATMENT OF BRAIN METASTASES (BM). TWELVE YEARS NEUROSURGICAL EXPERIENCE

by Carapella, Carmine, Albanese, Rosalinda, Telera, Stefano, Raus, Laura, Villani, Veronica, Fabi, Alessandra, Pace, Andrea
Published in Neuro Oncol (2017)

Impressive Long-term Response with Pertuzumab and Trastuzumab in HER2-positive Breast Cancer with Brain Metastasis

by RUSSILLO, MICHELANGELO, FERRETTI, GIANLUIGI, VIDIRI, ANTONELLO, GASPARRO, SIMONA, COGNETTI, FRANCESCO, PELLEGRINI, DOMENICA, FABI, ALESSANDRA
Published in In Vivo (2018)

Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations

by Allegretti, Matteo, Fabi, Alessandra, Buglioni, Simonetta, Martayan, Aline, Conti, Laura, Pescarmona, Edoardo, Ciliberto, Gennaro, Giacomini, Patrizio
Published in J Exp Clin Cancer Res (2018)

The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine

by Maschio, Marta, Dinapoli, Loredana, Vidiri, Antonello, Pace, Andrea, Fabi, Alessandra, Pompili, Alfredo, Carapella, Maria Carmine, Jandolo, Bruno
Published 2009

The Prognostic Value of Pyrosequencing-Detected MGMT Promoter Hypermethylation in Newly Diagnosed Patients with Glioblastoma

by Villani, Veronica, Casini, Beatrice, Pace, Andrea, Prosperini, Luca, Carapella, Carmine M., Vidiri, Antonello, Fabi, Alessandra, Carosi, Mariantonia
Published in Dis Markers (2015)

HCP-05 COMBINED MANAGEMENT AND THE ROLE OF COMORBIDITIES IN ELDERLY GLIOBLASTOMA

by Carapella, Carmine, Villani, Veronica, Zucchella, Chiara, Telera, Stefano, Sperduti, Isabella, Vidiri, Antonello, Fabi, Alessandra, Marucci, Laura, Pace, Andrea
Published in Neuro Oncol (2015)

Autoantibodies specific to estrogen receptor alpha act as estrogen agonists and their levels correlate with breast cancer cell proliferation

by Maselli, Angela, Capoccia, Sara, Pugliese, Patrizia, Raggi, Carla, Cirulli, Francesca, Fabi, Alessandra, Malorni, Walter, Pierdominici, Marina, Ortona, Elena
Published in Oncoimmunology (2015)

Oligometastatic Breast Cancer: How to Manage It?

by Barberi, Vittoria, Pietragalla, Antonella, Franceschini, Gianluca, Marazzi, Fabio, Paris, Ida, Cognetti, Francesco, Masetti, Riccardo, Scambia, Giovanni, Fabi, Alessandra
Published in J Pers Med (2021)

Quantitative analysis of CT-perfusion parameters in the evaluation of brain gliomas and metastases

by Di Nallo, Anna Maria, Vidiri, Antonello, Marzi, Simona, Mirri, Alessandra, Fabi, Alessandra, Carapella, Carmine Maria, Pace, Andrea, Crecco, Marcello
Published 2009

Use of rehabilitation pathways in women with breast cancer in the first 12 months of the disease: a retrospective study

by Falcicchio, Chiara, Di Lallo, Domenico, Fabi, Alessandra, Bonucci, Alessandro, Perrone, Maria, Pace, Andrea, Corti, Ambra, Giacomelli, Luca, Pugliese, Patrizia
Published in BMC Cancer (2021)

NI-11 THE POTENTIAL ROLE OF (18)F-FDOPA PET IMAGING IN THE EVALUATION OF LOW-GRADE GLIOMAS

by Carapella, Carmine, Chiaravalloti, Agostino, Villani, Veronica, Vidiri, Antonello, Piludu, Francesca, Terrenato, Irene, Fabi, Alessandra, Schillaci, Orazio, Pace, Andrea, Floris, Roberto
Published 2014

INNV-14. ADJUVANT CHEMOTHERAPY AFTER SEVERE MYELOTOXICITY DURING TEMOZOLOMIDE CHEMORADIATION IN GLIOMAS. IT IS FEASIBILE?

by Villani, Veronica, Fabi, Alessandra, Gaviani, Paola, Rudà, Roberta, Lombardi, Giuseppe, Simonetti, Giorgia, Silvani, Antonio, Pronello, Edoardo, Minniti, Giuseppe, Pace, Andrea
Published in Neuro Oncol (2019)

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study

by Lazzaro, Carlo, Bordonaro, Roberto, Cognetti, Francesco, Fabi, Alessandra, De Placido, Sabino, Arpino, Grazia, Marchetti, Paolo, Botticelli, Andrea, Pronzato, Paolo, Martelli, Elisa
Published 2013

Early perfusion changes in patients with recurrent high-grade brain tumor treated with Bevacizumab: preliminary results by a quantitative evaluation

by Vidiri, Antonello, Pace, Andrea, Fabi, Alessandra, Maschio, Marta, Latagliata, Gaetano Marco, Anelli, Vincenzo, Piludu, Francesca, Carapella, Carmine Maria, Giovinazzo, Giuseppe, Marzi, Simona
Published 2012

Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: efficacy in combination wit...

by Fabi Alessandra, Russillo Michelangelo, Ferretti Gianluigi, Metro Giulio, Nisticò Cecilia, Papaldo Paola, De Vita Ferdinando, D’Auria Giuliana, Vidiri Antonello, Giannarelli Diana, Cognetti Francesco
Published 2012-10-01

Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: efficacy in combination wit...

by Fabi, Alessandra, Russillo, Michelangelo, Ferretti, Gianluigi, Metro, Giulio, Nisticò, Cecilia, Papaldo, Paola, De Vita, Ferdinando, D’Auria, Giuliana, Vidiri, Antonello, Giannarelli, Diana, Cognetti, Francesco
Published 2012